BeOne Medicines Ltd. (Nasdaq: ONC; HKEX: 06160; SSE: 688235), a global oncology company, today announced positive topline results from the Phase 3 MANGROVE ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results